Clinical trial
Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment…
NCT00373516 · QuatRx Pharmaceuticals Company, Industry · Completed
Key facts
| NCT number | NCT00373516 |
|---|---|
| Title | Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis |
| Official title | A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Study of the Safety and Efficacy of Two Dosing Regimens of QRX-101 (Becocalcidiol) Ointment in the Treatment of Plaque-Type Psoriasis |
| Lead sponsor | QuatRx Pharmaceuticals Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Vehicle (Placebo) applied BID, QRX-101 75 mcg/g ointment applied QD, QRX-101 75 mcg/g ointment applied BID |
| Enrollment | 150 |
| Start date | Sep 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Sep 8, 2006 |
| Last update posted | Sep 8, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: